ACTR-88. A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS Article

Dixit, Karan, Kumthekar, Priya, Kruser, Timothy et al. (2017). ACTR-88. A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS . NEURO-ONCOLOGY, 19(suppl_6), vi19-vi20. 10.1093/neuonc/nox168.073

cited authors

  • Dixit, Karan; Kumthekar, Priya; Kruser, Timothy; Sachdev, Sean; Kalapurakal, John A; Gondi, Vinai; Grimm, Sean; Nicholas, Martin; Lukas, Rimas V; Chmura, Steven J; Mehta, Minesh P; Raizer, Jeffrey

authors

publication date

  • November 6, 2017

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • 6.5 Radiotherapy and other non-invasive therapies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Rare Diseases
  • Vaccine Related

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi19

end page

  • vi20

volume

  • 19

issue

  • suppl_6